Next Quarterly Earnings
Thursday, August 6, 2026
CW 32
Pre-Market
In 32 days
Prime Medicine is a leading biotechnology company focused on precise gene editing. Utilizing its innovative Prime Editing technology, it is developing transformative therapies to address a wide spectrum of genetic diseases. The company aims to fundamentally correct genomic defects, revolutionizing medicine.